These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15797184)

  • 1. Mucopolysaccharidosis type II in females: case report and review of literature.
    Tuschl K; Gal A; Paschke E; Kircher S; Bodamer OA
    Pediatr Neurol; 2005 Apr; 32(4):270-2. PubMed ID: 15797184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele.
    Sukegawa K; Song XQ; Masuno M; Fukao T; Shimozawa N; Fukuda S; Isogai K; Nishio H; Matsuo M; Tomatsu S; Kondo N; Orii T
    Hum Mutat; 1997; 10(5):361-7. PubMed ID: 9375851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in the iduronate 2 sulfatase gene resulting in mucopolysaccharidosis type II and chorea: case report of two siblings.
    Farooq MU; Balmer SV; DeRoos ST; Houtman KL; Chillag KL
    Mov Disord; 2008 Jul; 23(10):1487-8. PubMed ID: 18546295
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation.
    Piña-Aguilar RE; Zaragoza-Arévalo GR; Rau I; Gal A; Alcántara-Ortigoza MA; López-Martínez MS; Santillán-Hernández Y
    Eur J Med Genet; 2013 Mar; 56(3):159-62. PubMed ID: 23232253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
    Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV
    BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).
    Schröder W; Wulff K; Wehnert M; Seidlitz G; Herrmann FH
    Hum Mutat; 1994; 4(2):128-31. PubMed ID: 7981716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
    Martin R; Beck M; Eng C; Giugliani R; Harmatz P; Muñoz V; Muenzer J
    Pediatrics; 2008 Feb; 121(2):e377-86. PubMed ID: 18245410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and molecular analysis in a patient with the severe form of Hunter syndrome after bone marrow transplantation.
    Li P; Thompson JN; Hug G; Huffman P; Chuck G
    Am J Med Genet; 1996 Sep; 64(4):531-5. PubMed ID: 8870917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prenatal diagnosis of mucopolysaccharidosis type II].
    Zhang XS; Zhang HW; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Oct; 28(5):536-8. PubMed ID: 21983729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations.
    Kim CH; Hwang HZ; Song SM; Paik KH; Kwon EK; Moon KB; Yoon JH; Han CK; Jin DK
    Hum Mutat; 2003 Apr; 21(4):449-50. PubMed ID: 12655569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mucopolysaccharidosis II (Hunter syndrome): identification of the carrier state of the disease by means of mutation analysis].
    Balzano N; Villani GR; Coppa G; Di Natale P
    Pediatr Med Chir; 1996; 18(1):91-3. PubMed ID: 8685031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iduronate sulfatase activity in serum, lymphocytes, and fibroblasts--simplified diagnosis of the Hunter syndrome.
    Liebaers I; Neufeld E
    Pediatr Res; 1976 Aug; 10(8):733-6. PubMed ID: 821034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients.
    Sukegawa K; Tomatsu S; Fukao T; Iwata H; Song XQ; Yamada Y; Fukuda S; Isogai K; Orii T
    Hum Mutat; 1995; 6(2):136-43. PubMed ID: 7581397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome: a consequence of twinning.
    Winchester B; Young E; Geddes S; Genet S; Hurst J; Middleton-Price H; Williams N; Webb M; Habel A; Malcolm S
    Am J Med Genet; 1992 Dec; 44(6):834-8. PubMed ID: 1481858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome).
    Papadia F; Lozupone MS; Gaeta A; Capodiferro D; Lacalendola G
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):253-8. PubMed ID: 21528770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.
    Hopwood JJ; Bunge S; Morris CP; Wilson PJ; Steglich C; Beck M; Schwinger E; Gal A
    Hum Mutat; 1993; 2(6):435-42. PubMed ID: 8111411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome).
    Popowska E; Rathmann M; Tylki-Szymanska A; Bunge S; Steglich C; Schwinger E; Gal A
    Hum Mutat; 1995; 5(1):97-100. PubMed ID: 7728156
    [No Abstract]   [Full Text] [Related]  

  • 20. The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.
    Chkioua L; Grissa O; Leban N; Gribaa M; Boudabous H; Turkia HB; Ferchichi S; Tebib N; Laradi S
    BMC Med Genet; 2020 May; 21(1):111. PubMed ID: 32448126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.